However, estrogens might activate neuronal MMP-2 and MMP-9, which can degrade amyloid peptides in cell culture [88], so their increased activation may represent a compensatory mechanism rather than evidence of their undesirable contribution to AD pathophysiology. Here, MMP9 is linked to Alzheimer disease.